Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 187,540 | 151,791 | 139,915 | 130,132 | 148,663 |
| Marketable Securities | 0 | 1,072 | 5,397 | 5,520 | 0 |
| Receivables | 223,688 | 241,394 | 227,887 | 207,451 | 204,570 |
| Inventories | 185,041 | 179,731 | 179,496 | 180,839 | 186,080 |
| Other current assets | 52,298 | 43,431 | 57,955 | 66,698 | 52,164 |
| TOTAL | $648,567 | $617,419 | $610,650 | $590,640 | $591,477 |
| Non-Current Assets | |||||
| PPE Net | 253,939 | 251,154 | 243,728 | 234,204 | 231,683 |
| Intangibles | 1,468,589 | 1,479,744 | 1,497,394 | 1,530,687 | 1,548,347 |
| Other Non-Current Assets | 364,922 | 355,550 | 369,398 | 375,222 | 383,853 |
| TOTAL | $2,087,450 | $2,086,448 | $2,110,520 | $2,140,113 | $2,163,883 |
| Total Assets | $2,736,017 | $2,703,867 | $2,721,170 | $2,730,753 | $2,755,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 31,559 | 37,968 | 28,895 | 31,514 | 29,834 |
| Accrued Expenses | 63,065 | 74,704 | 62,119 | 50,154 | 50,828 |
| Other current liabilities | 30,883 | 30,081 | 33,746 | 34,245 | 28,956 |
| TOTAL | $142,128 | $159,379 | $149,820 | $135,231 | $127,754 |
| Non-Current Liabilities | |||||
| Long Term Debt | 300,000 | 319,000 | 389,000 | 447,000 | 440,000 |
| Other Non-Current Liabilities | 105,222 | 100,775 | 104,309 | 113,388 | 106,726 |
| TOTAL | $455,239 | $475,638 | $556,975 | $631,963 | $629,860 |
| Total Liabilities | $597,367 | $635,017 | $706,795 | $767,194 | $757,614 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 158,892 | 158,600 | 157,585 | 157,192 | 158,150 |
| Common Shares | 1,589 | 1,582 | 1,576 | 1,571 | 1,584 |
| Retained earnings | 1,341,175 | 1,325,247 | 1,297,688 | 1,261,376 | 1,327,572 |
| Other shareholders' equity | -60,087 | -78,316 | -75,307 | -63,661 | -78,016 |
| TOTAL | $2,138,650 | $2,068,850 | $2,014,375 | $1,963,559 | $1,997,746 |
| Total Liabilities And Equity | $2,736,017 | $2,703,867 | $2,721,170 | $2,730,753 | $2,755,360 |